Catalyst Wire Dossier Catalyst Wire Dossier

SBS-1000

SBS-1000 · Sparian Biosciences, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SBS-1000, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults [Phase 1]

See pricing